Progyny, Inc. Proceeds from Stock Options Exercised
Progyny, Inc. (PGNY) reported Proceeds from Stock Options Exercised of $31.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-07
- Progyny, Inc. proceeds from stock options exercised for the quarter ending 2026-06-30 was $1.00K.
- Progyny, Inc. proceeds from stock options exercised for the quarter ending 2026-03-31 was $30.00K, a 23.08% decline year-over-year.
- Progyny, Inc. proceeds from stock options exercised for the quarter ending 2025-12-31 was $63.00K, a 3050.00% increase year-over-year.
- Progyny, Inc. proceeds from stock options exercised for the quarter ending 2025-09-30 was $5.00K, a 95.41% decline year-over-year.
- Progyny, Inc. proceeds from stock options exercised for fiscal 2025 was $86.00K, a 92.17% decline from fiscal 2024.
- Progyny, Inc. proceeds from stock options exercised for fiscal 2024 was $1.10M, a 77.34% decline from fiscal 2023.
- Progyny, Inc. proceeds from stock options exercised for fiscal 2023 was $4.85M, a 57.83% increase from fiscal 2022.
- Progyny, Inc. proceeds from stock options exercised for fiscal 2022 was $3.07M, a 5.10% increase from fiscal 2021.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $31.00K 10-Q · filed 2026-08-07 | $94.00K derived: sum of 3 quarters · filed 2026-08-07 | $99.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $30.00K 10-Q · filed 2026-05-08 | $93.00K derived: sum of 2 quarters · filed 2026-05-08 | $98.00K derived: sum of 3 quarters · filed 2026-05-08 | $77.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $68.00K derived: sum of 2 quarters · filed 2026-02-27 | $47.00K derived: sum of 3 quarters · filed 2026-08-07 | $86.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$16.00K derived: sum of 2 quarters · filed 2026-08-07 | $23.00K 10-Q · filed 2025-11-07 | $25.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $18.00K 10-Q · filed 2026-08-07 | $20.00K derived: sum of 3 quarters · filed 2026-08-07 | $129.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $39.00K 10-Q · filed 2026-05-08 | $41.00K derived: sum of 2 quarters · filed 2026-05-08 | $150.00K derived: sum of 3 quarters · filed 2026-05-08 | $176.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $111.00K derived: sum of 2 quarters · filed 2026-02-27 | $137.00K derived: sum of 3 quarters · filed 2026-02-27 | $1.10M 10-K · filed 2026-02-27 |
| 2024-09-30 | $109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $135.00K derived: sum of 2 quarters · filed 2025-11-07 | $1.10M 10-Q · filed 2025-11-07 | $2.37M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $988.00K 10-Q · filed 2025-08-08 | $2.27M derived: sum of 3 quarters · filed 2026-02-27 | $2.71M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $962.00K 10-Q · filed 2025-05-09 | $2.24M derived: sum of 2 quarters · filed 2026-02-27 | $2.69M derived: sum of 3 quarters · filed 2026-02-27 | $4.14M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.73M derived: sum of 2 quarters · filed 2026-02-27 | $3.17M derived: sum of 3 quarters · filed 2026-02-27 | $4.85M 10-K · filed 2026-02-27 |
| 2023-09-30 | $449.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.90M derived: sum of 2 quarters · filed 2024-11-12 | $3.57M 10-Q · filed 2024-11-12 | $4.52M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $3.12M 10-Q · filed 2024-08-07 | $4.07M derived: sum of 3 quarters · filed 2025-03-03 | $4.99M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $1.68M 10-Q · filed 2024-05-10 | $2.62M derived: sum of 2 quarters · filed 2025-03-03 | $3.54M derived: sum of 3 quarters · filed 2025-03-03 | $3.92M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $943.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $1.86M derived: sum of 2 quarters · filed 2025-03-03 | $2.24M derived: sum of 3 quarters · filed 2025-03-03 | $3.07M 10-K · filed 2025-03-03 |
| 2022-09-30 | $921.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.30M derived: sum of 2 quarters · filed 2023-11-08 | $2.13M 10-Q · filed 2023-11-08 | $3.30M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $379.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $1.21M 10-Q · filed 2023-08-04 | $2.38M derived: sum of 3 quarters · filed 2024-02-29 | $2.94M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $830.00K 10-Q · filed 2023-05-09 | $2.00M derived: sum of 2 quarters · filed 2024-02-29 | $2.56M derived: sum of 3 quarters · filed 2024-02-29 | $3.21M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.73M derived: sum of 2 quarters · filed 2024-02-29 | $2.38M derived: sum of 3 quarters · filed 2024-02-29 | $2.92M 10-K · filed 2024-02-29 |
| 2021-09-30 | $562.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $1.21M derived: sum of 2 quarters · filed 2022-11-04 | $1.75M 10-Q · filed 2022-11-04 | $2.00M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $652.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $1.19M 10-Q · filed 2022-08-05 | $1.44M derived: sum of 3 quarters · filed 2023-03-01 | $2.09M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $539.00K 10-Q · filed 2022-05-06 | $790.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.44M derived: sum of 3 quarters · filed 2023-03-01 | $2.27M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $900.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.73M derived: sum of 3 quarters · filed 2023-03-01 | $2.33M 10-K · filed 2023-03-01 |
| 2020-09-30 | $649.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $1.48M derived: sum of 2 quarters · filed 2021-11-08 | $2.08M 10-Q · filed 2021-11-08 | $3.61M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $832.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $1.43M 10-Q · filed 2021-08-06 | $2.96M derived: sum of 3 quarters · filed 2022-03-01 | $7.93M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $597.00K 10-Q · filed 2021-05-07 | $2.13M derived: sum of 2 quarters · filed 2022-03-01 | $7.10M derived: sum of 3 quarters · filed 2022-03-01 | $7.13M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $6.50M derived: sum of 2 quarters · filed 2022-03-01 | $6.53M derived: sum of 3 quarters · filed 2022-03-01 | $6.54M 10-K · filed 2022-03-01 |
| 2019-09-30 | $4.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $5.00M derived: sum of 2 quarters · filed 2020-11-06 | $5.01M 10-Q · filed 2020-11-06 | $5.03M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $31.00K 10-Q · filed 2020-08-07 | $50.00K derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-03-31 | $2.00K 10-Q · filed 2020-05-14 | $21.00K derived: sum of 2 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $65.00K 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $46.00K 10-Q · filed 2019-12-06 | |||
| 2017-12-31 | $25.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |